What’s Happening
Trelli has officially launched Relivaid, a new pain support supplement designed to target inflammation, muscle and joint discomfort, and common pain points such as headaches and menstrual cramps.
Relivaid is positioned as a fast-acting, single-dose formula built entirely around naturally derived bioactive ingredients. The product is designed to deliver relief within minutes while avoiding the traditional active ingredients commonly found in over-the-counter pain medications.
The formula is built around three primary components. It includes a phospholipid-complexed PEA (palmitoylethanolamide), a compound produced by the body that plays a role in regulating pain and inflammation. It also features a specialized ginger extract standardized for active compounds associated with anti-inflammatory effects, along with a low dose of caffeine to support faster absorption and enhance the overall effect.
Relivaid is designed to support a range of use cases, including tension headaches, menstrual cramps, joint pain, muscle soreness, and general inflammation.
The product leverages advanced delivery technology to improve bioavailability, with the goal of increasing how quickly and effectively the active ingredients are absorbed by the body.
Relivaid officially launched in April 2026 and is available directly through the brand’s website as its first product release.
Why It Matters
Relivaid represents a shift toward alternative pain management solutions that move away from traditional pharmaceutical ingredients.
The product is positioned to appeal to consumers who are looking for effective relief while avoiding the long-term risks associated with frequent use of conventional OTC pain medications.
By focusing on clinically studied, naturally derived ingredients paired with advanced delivery systems, the product is targeting a gap between supplements and traditional medicine.
Bigger Picture
The pain relief category is starting to see disruption from supplement-style products that aim to replicate or support the body’s natural response to inflammation and discomfort.
As consumers become more cautious about ingredient safety and long-term use, there is growing demand for alternatives that combine clinical backing with cleaner formulations, pushing the category beyond traditional OTC solutions.
Sources
Fitt Insider – https://insider.fitt.co/press-release/trelli-launches-relivaid-bringing-clinically-validated-bioavailability-technology-to-naturally-derived-pain-relief/
Startup CPG – https://startupcpg.com/newswire/startup-cpg-newswire-trelli-announces-april-2026-launch-with-relivaid-a-science-first-alternative-to-conventional-otc-pain-relief/